Optometry News

CARLSBAD, Calif. — A sustained-release intravitreal hydrogel implant containing axitinib demonstrated durable results in patients with neovascular age-related macular degeneration, according to phase 1 study results.

BARCELONA, Spain — A subgroup analysis of the DAVIO 2 trial showed that eyes implanted with the EYP-1901 intravitreal insert maintained stable visual acuity with strong anatomic control over 8 months, according to a presenter.

When investing, time in the market is arguably as important as well-publicized factors, such as rate of return, initial amount of investment (principal) and costs of investing.

The global optometric community is joining together to recognize the World Sight Day Challenge during the months of September and October, highlighted by a day of awareness on Oct. 10.

For ophthalmologists, saying “no” is not a weakness but an important step for long-term success, according to a presentation at Real World Ophthalmology.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Anat Loewenstein, MD, MHA, speaks about 4D-150, a novel intravitreally administered gene therapy for wet age-related macular degeneration.

As Healio recently reported, proposed reforms to the NIH, which include folding the National Eye Institute into a multi-specialty grouping, could significantly affect research and have prompted several advocacy organizations to take action.

BARCELONA, Spain — Optimizing the use of donor tissue through hemi- and quarter-Descemet’s membrane endothelial keratoplasty can maximize the number of transplants per donor, according to a speaker here.

Retinal layer thickness gradually decreased over time in cognitively healthy older adults, but was not associated with baseline demographic factors such as age, sex, IOP or cognitive scores, according to a study published in Retina.

The loss of UBAP1L gene function appears to be associated with nonsyndromic retinal dystrophy, according to research published in JAMA Ophthalmology.